Neogen (NEOG) EBITDA (2010 - 2026)

Neogen's EBITDA history runs 17 years deep, the most recent figure standing at -$3.3 million for Q1 2026.

• On a quarterly basis, EBITDA fell 161.11% year-over-year to -$3.3 million in Q1 2026; TTM through Feb 2026 was -$636.0 million, a 45.6% decrease from a year earlier, with the FY2025 full-year figure at -$1.1 billion, down 1908.63% from the prior year.
• EBITDA rose to -$3.3 million in Q1 2026 per NEOG's latest filing, from -$5.4 million in the prior quarter.
• Across five years, EBITDA topped out at $23.4 million in Q2 2023 and bottomed at -$611.2 million in Q2 2025.
• The 5-year median for EBITDA is $6.1 million (2022), against an average of -$56.8 million.
• Across the five-year window, EBITDA jumped 288.94% in 2023 and plunged 4787.09% in 2025, its largest moves.
• Year by year, EBITDA stood at -$7.7 million in 2022, then soared by 288.94% to $14.5 million in 2023, then plunged by 3262.7% to -$457.5 million in 2024, then soared by 98.82% to -$5.4 million in 2025, then soared by 38.63% to -$3.3 million in 2026.
• Per Business Quant, the three latest NEOG EBITDA figures stand at -$3.3 million (Q1 2026), -$5.4 million (Q4 2025), and -$16.1 million (Q3 2025).